Gallbladder cancer
ICD-10 C23 · ICD-11 2C13

Treatment of Resectable Gallbladder Carcinoma with No Metastatic Spread

Clinical scenario

This protocol applies to patients with gallbladder carcinoma (GBC) where imaging and evaluation confirm no distant metastatic spread and the tumour is considered surgically resectable. Determining resectability is the central step: when GBC is diagnosed on imaging or when patients present with jaundice, assessment of potential resectability guides all subsequent management decisions. This assessment should be carried out by a specialist hepatobiliary multidisciplinary tumour board.

Treatment approach (overview)

Surgery is the only modality with the potential to cure this disease. The approach involves radical curative-intent resection, which includes removal of regional lymph nodes (lymphadenectomy). The specific extent of the resection depends on tumour location and the degree of local invasion — additional structures beyond the gallbladder itself may need to be addressed to achieve the surgical goal.

The complete surgical algorithm, including the specific anatomical resection criteria for each tumour location, is available in the full structured protocol.

Surgical goal

The primary objective of the operation is:

R0 resection — no tumour at the resection margin
Instant Access to Structured Evidence-Based Regimens
References

DOI: 10.1016/j.annonc.2022.10.506

View source ↗